Literature DB >> 6709027

The pharmacokinetics of heroin in patients with chronic pain.

C E Inturrisi, M B Max, K M Foley, M Schultz, S U Shin, R W Houde.   

Abstract

We measured blood concentrations of heroin and its active metabolites, 6-acetylmorphine and morphine, serially in 11 patients with chronic pain (9 of whom had cancer) after intravenous injection, intravenous infusion, intramuscular injection, and an oral dose of heroin hydrochloride. Parenteral heroin provided measureable blood levels of heroin, 6-acetylmorphine, and morphine. Blood levels of heroin and 6-acetylmorphine reached their maximal concentrations within minutes and were cleared rapidly. The mean half-life of heroin (+/- S.D.) after intravenous injection or infusion was only 3.0 +/- 1.3 minutes, and the mean clearance of heroin from the blood at apparent steady state was 30.8 +/- 2.1 ml per kilogram of body weight per minute. Morphine levels rose more gradually, and morphine was cleared much more slowly. Oral administration of heroin resulted in measurable blood levels of morphine but not of heroin or 6-acetylmorphine. The amount of circulating morphine provided by an oral dose of heroin was only 79 per cent of that available from an equal amount of morphine. We conclude that heroin is a pro-drug that serves to determine the distribution of its active metabolites. Parenteral heroin is rapidly converted to 6-acetylmorphine, which contributes to rapid pain relief. Oral heroin is converted to morphine and appears to be an inefficient means of providing morphine to the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709027     DOI: 10.1056/NEJM198405103101902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

Review 1.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Prodrugs.

Authors:  D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

4.  Evaluation of a solid-phase extraction procedure for the simultaneous determination of morphine, 6-monoacetylmorphine, codeine and dihydrocodeine in plasma and whole blood by GC/MS.

Authors:  A Geier; D Bergemann; L von Meyer
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

5.  Teaching terminal care.

Authors:  P M Kaye
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

6.  A practical approach to improving pain control in cancer patients.

Authors:  M L Brigden; J B Barnett
Journal:  West J Med       Date:  1987-05

7.  Population pharmacokinetics of heroin and its major metabolites.

Authors:  Elisabeth J Rook; Alwin D R Huitema; Wim van den Brink; Jan M van Ree; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 8.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

9.  Morphine kinetics after diamorphine infusion in premature neonates.

Authors:  D A Barrett; A C Elias-Jones; N Rutter; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

10.  High levels of morphine-6-glucuronide in street heroin addicts.

Authors:  Letizia Antonilli; Federico Semeraro; Carmen Suriano; Luciano Signore; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.